Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Delivery and impact of the NHS Health Check in the first 8 years: a systematic review.

Martin A, Saunders CL, Harte E, Griffin SJ, MacLure C, Mant J, Meads C, Walter FM, Usher-Smith JA.

Br J Gen Pract. 2018 Jul;68(672):e449-e459. doi: 10.3399/bjgp18X697649. Epub 2018 Jun 18.

PMID:
29914882
2.

Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: An Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma.

Wilson ECF, Usher-Smith JA, Emery J, Corrie PG, Walter FM.

Value Health. 2018 Jun;21(6):669-676. doi: 10.1016/j.jval.2017.10.009. Epub 2017 Dec 8.

PMID:
29909871
3.

A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom.

Wilson ECF, Usher-Smith JA, Emery J, Corrie P, Walter FM.

Value Health. 2018 Jun;21(6):658-668. doi: 10.1016/j.jval.2017.11.009. Epub 2018 Apr 11.

PMID:
29909870
4.

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence.

Brett J, Boulton M, Fenlon D, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery BA, Morgan A, Morris C, Watson EK.

Patient Prefer Adherence. 2018 Feb 16;12:291-300. doi: 10.2147/PPA.S145784. eCollection 2018.

5.

The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia.

Emery JD, Gray V, Walter FM, Cheetham S, Croager EJ, Slevin T, Saunders C, Threlfall T, Auret K, Nowak AK, Geelhoed E, Bulsara M, Holman CDJ.

Br J Cancer. 2018 Mar 20;118(6):e8. doi: 10.1038/bjc.2017.457. Epub 2018 Feb 15.

6.

Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.

Stewart TS, Moodley J, Walter FM.

Cancer Epidemiol. 2018 Apr;53:81-92. doi: 10.1016/j.canep.2018.01.014. Epub 2018 Feb 4.

PMID:
29414636
7.

External validation of risk prediction models for incident colorectal cancer using UK Biobank.

Usher-Smith JA, Harshfield A, Saunders CL, Sharp SJ, Emery J, Walter FM, Muir K, Griffin SJ.

Br J Cancer. 2018 Mar 6;118(5):750-759. doi: 10.1038/bjc.2017.463. Epub 2018 Jan 30.

8.

Psychometric properties of the Beliefs about Medicine Questionnaire-adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer.

Brett J, Hulbert-Williams NJ, Fenlon D, Boulton M, Walter FM, Donnelly P, Lavery B, Morgan A, Morris C, Horne R, Watson E.

Health Psychol Open. 2017 Nov 17;4(2):2055102917740469. doi: 10.1177/2055102917740469. eCollection 2017 Jul-Dec.

9.

Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV).

Watson EK, Shinkins B, Matheson L, Burns RM, Frith E, Neal D, Hamdy F, Walter FM, Weller D, Wilkinson C, Faithfull S, Sooriakumaran P, Kastner C, Campbell C, Neal RD, Butcher H, Matthews M, Perera R, Wolstenholme J, Rose PW.

Eur J Oncol Nurs. 2018 Feb;32:73-81. doi: 10.1016/j.ejon.2017.12.002. Epub 2017 Dec 29.

PMID:
29353635
10.

Associations between diagnostic activity and measures of patient experience in primary care: a cross-sectional ecological study of English general practices.

Lyratzopoulos G, Mendonca SC, Gildea C, McPhail S, Peake MD, Rubin G, Singh H, Hamilton W, Walter FM, Roland M, Abel GA.

Br J Gen Pract. 2018 Jan;68(666):e9-e17. doi: 10.3399/bjgp17X694097. Epub 2017 Dec 18.

11.

Symptom Signatures and Diagnostic Timeliness in Cancer Patients: A Review of Current Evidence.

Koo MM, Hamilton W, Walter FM, Rubin GP, Lyratzopoulos G.

Neoplasia. 2018 Feb;20(2):165-174. doi: 10.1016/j.neo.2017.11.005. Epub 2017 Dec 16. Review.

12.

The researchers' role in knowledge translation: a realist evaluation of the development and implementation of diagnostic pathways for cancer in two United Kingdom localities.

Banks J, Wye L, Hall N, Rooney J, Walter FM, Hamilton W, Gjini A, Rubin G.

Health Res Policy Syst. 2017 Dec 13;15(1):103. doi: 10.1186/s12961-017-0267-8.

13.

Possible missed opportunities for diagnosing colorectal cancer in Dutch primary care: a multimethods approach.

Brandenbarg D, Groenhof F, Siewers IM, van der Voort A, Walter FM, Berendsen AJ.

Br J Gen Pract. 2018 Jan;68(666):e54-e62. doi: 10.3399/bjgp17X693905. Epub 2017 Dec 4.

PMID:
29203683
14.

Reasons why people do not attend NHS Health Checks: a systematic review and qualitative synthesis.

Harte E, MacLure C, Martin A, Saunders CL, Meads C, Walter FM, Griffin SJ, Mant J, Usher-Smith JA.

Br J Gen Pract. 2018 Jan;68(666):e28-e35. doi: 10.3399/bjgp17X693929. Epub 2017 Dec 4.

15.

Protocol for the melatools skin self-monitoring trial: a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma.

Mills K, Emery J, Lantaff R, Radford M, Pannebakker M, Hall P, Burrows N, Williams K, Saunders CL, Murchie P, Walter FM.

BMJ Open. 2017 Nov 28;7(11):e017934. doi: 10.1136/bmjopen-2017-017934.

16.

Variation in 'fast-track' referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites.

Zhou Y, Mendonca SC, Abel GA, Hamilton W, Walter FM, Johnson S, Shelton J, Elliss-Brookes L, McPhail S, Lyratzopoulos G.

Br J Cancer. 2018 Jan;118(1):24-31. doi: 10.1038/bjc.2017.381. Epub 2017 Nov 28.

17.

Reducing barriers to consulting a General Practitioner in patients at increased risk of lung cancer: a qualitative evaluation of the CHEST Australia intervention.

Murray SR, Kutzer Y, Habgood E, Murchie P, Walter FM, Mazza D, Shahid S, Emery JD.

Fam Pract. 2017 Nov 16;34(6):740-746. doi: 10.1093/fampra/cmx057.

PMID:
29155969
18.

Views of commissioners, managers and healthcare professionals on the NHS Health Check programme: a systematic review.

Mills K, Harte E, Martin A, MacLure C, Griffin SJ, Mant J, Meads C, Saunders CL, Walter FM, Usher-Smith JA.

BMJ Open. 2017 Nov 15;7(11):e018606. doi: 10.1136/bmjopen-2017-018606. Review.

19.

pedigreejs: a web-based graphical pedigree editor.

Carver T, Cunningham AP, Babb de Villiers C, Lee A, Hartley S, Tischkowitz M, Walter FM, Easton DF, Antoniou AC.

Bioinformatics. 2018 Mar 15;34(6):1069-1071. doi: 10.1093/bioinformatics/btx705.

20.

The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia.

Emery JD, Gray V, Walter FM, Cheetham S, Croager EJ, Slevin T, Saunders C, Threlfall T, Auret K, Nowak AK, Geelhoed E, Bulsara M, Holman CDJ.

Br J Cancer. 2017 Nov 7;117(10):1459-1469. doi: 10.1038/bjc.2017.310. Epub 2017 Sep 19. Erratum in: Br J Cancer. 2018 Feb 15;:.

21.

Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: a qualitative study.

Mills K, Birt L, Emery JD, Hall N, Banks J, Johnson M, Lancaster J, Hamilton W, Rubin GP, Walter FM.

BMJ Open. 2017 Sep 3;7(9):e015682. doi: 10.1136/bmjopen-2016-015682.

22.

Measures of psychosocial factors that may influence help-seeking behaviour in cancer: A systematic review of psychometric properties.

Kummer S, Walter FM, Chilcot J, Scott S.

J Health Psychol. 2017 May 1:1359105317707255. doi: 10.1177/1359105317707255. [Epub ahead of print]

PMID:
28810457
23.

Patient experience of NHS health checks: a systematic review and qualitative synthesis.

Usher-Smith JA, Harte E, MacLure C, Martin A, Saunders CL, Meads C, Walter FM, Griffin SJ, Mant J.

BMJ Open. 2017 Aug 11;7(8):e017169. doi: 10.1136/bmjopen-2017-017169. Review.

24.

Diagnosing adult primary brain tumours: can we do better?

Penfold C, Joannides AJ, Bell J, Walter FM.

Br J Gen Pract. 2017 Jun;67(659):278-279. doi: 10.3399/bjgp17X691277. No abstract available.

25.

Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study.

Walter FM, Mills K, Mendonça SC, Abel GA, Basu B, Carroll N, Ballard S, Lancaster J, Hamilton W, Rubin GP, Emery JD.

Lancet Gastroenterol Hepatol. 2016 Dec;1(4):298-306. doi: 10.1016/S2468-1253(16)30079-6. Epub 2016 Oct 4.

26.

Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study.

Freeman M, Offman J, Walter FM, Sasieni P, Smith SG.

BMJ Open. 2017 Mar 1;7(3):e013901. doi: 10.1136/bmjopen-2016-013901.

27.

The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care.

Walker JG, Bickerstaffe A, Hewabandu N, Maddumarachchi S, Dowty JG; CRECRC, Jenkins M, Pirotta M, Walter FM, Emery JD.

BMC Med Inform Decis Mak. 2017 Jan 19;17(1):13. doi: 10.1186/s12911-017-0407-7.

28.

Identifying people at higher risk of melanoma across the U.K.: a primary-care-based electronic survey.

Usher-Smith JA, Kassianos AP, Emery JD, Abel GA, Teoh Z, Hall S, Neal RD, Murchie P, Walter FM.

Br J Dermatol. 2017 Apr;176(4):939-948. doi: 10.1111/bjd.15181. Epub 2016 Dec 23.

PMID:
28009060
29.

Factors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancer.

Brett J, Fenlon D, Boulton M, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery B, Morgan A, Morris C, Watson E.

Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12601. Epub 2016 Nov 30.

PMID:
27901302
30.
31.

Diagnosis of cancer as an emergency: a critical review of current evidence.

Zhou Y, Abel GA, Hamilton W, Pritchard-Jones K, Gross CP, Walter FM, Renzi C, Johnson S, McPhail S, Elliss-Brookes L, Lyratzopoulos G.

Nat Rev Clin Oncol. 2017 Jan;14(1):45-56. doi: 10.1038/nrclinonc.2016.155. Epub 2016 Oct 11. Review.

PMID:
27725680
32.

Improving early diagnosis of symptomatic cancer.

Hamilton W, Walter FM, Rubin G, Neal RD.

Nat Rev Clin Oncol. 2016 Dec;13(12):740-749. doi: 10.1038/nrclinonc.2016.109. Epub 2016 Jul 26. Review.

PMID:
27458007
33.

Using willingness-to-pay to establish patient preferences for cancer testing in primary care.

Hollinghurst S, Banks J, Bigwood L, Walter FM, Hamilton W, Peters TJ.

BMC Med Inform Decis Mak. 2016 Aug 9;16:105. doi: 10.1186/s12911-016-0345-9.

34.

Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study.

Walter FM, Emery JD, Mendonca S, Hall N, Morris HC, Mills K, Dobson C, Bankhead C, Johnson M, Abel GA, Rutter MD, Hamilton W, Rubin GP.

Br J Cancer. 2016 Aug 23;115(5):533-41. doi: 10.1038/bjc.2016.221. Epub 2016 Aug 4.

35.

Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms.

Paterson AL, Lao-Sirieix P, O'Donovan M, Debiram-Beecham I, di Pietro M, Miremadi A, Attwood SE, Walter FM, Sasieni PD, Fitzgerald RC; BEST and BEST2 study groups.

Histopathology. 2017 Jan;70(2):203-210. doi: 10.1111/his.13039. Epub 2016 Oct 12.

PMID:
27417524
36.

Risk prediction models for colorectal cancer in people with symptoms: a systematic review.

Williams TG, Cubiella J, Griffin SJ, Walter FM, Usher-Smith JA.

BMC Gastroenterol. 2016 Jun 13;16(1):63. doi: 10.1186/s12876-016-0475-7. Review.

37.

Predicting the Risk of Melanoma.

Emery JD, Usher-Smith JA, Walter FM.

JAMA Dermatol. 2016 Aug 1;152(8):875-7. doi: 10.1001/jamadermatol.2016.1574. No abstract available.

PMID:
27275772
38.

What Are the Key Elements of Educational Interventions for Lay Carers of Patients With Advanced Disease? A Systematic Literature Search and Narrative Review of Structural Components, Processes and Modes of Delivery.

Farquhar M, Penfold C, Walter FM, Kuhn I, Benson J.

J Pain Symptom Manage. 2016 Jul;52(1):117-130.e27. doi: 10.1016/j.jpainsymman.2015.12.341. Epub 2016 Apr 23. Review.

PMID:
27112309
39.

Evaluating a computer aid for assessing stomach symptoms (ECASS): study protocol for a randomised controlled trial.

Moore HJ, Nixon C, Tariq A, Emery J, Hamilton W, Hoare Z, Kershenbaum A, Neal RD, Ukoumunne OC, Usher-Smith J, Walter FM, Whyte S, Rubin G.

Trials. 2016 Apr 4;17:184. doi: 10.1186/s13063-016-1307-3.

40.

Symptoms of adult chronic and acute leukaemia before diagnosis: large primary care case-control studies using electronic records.

Shephard EA, Neal RD, Rose PW, Walter FM, Hamilton W.

Br J Gen Pract. 2016 Mar;66(644):e182-8. doi: 10.3399/bjgp16X683989.

41.
42.

Risk prediction tools for cancer in primary care.

Usher-Smith J, Emery J, Hamilton W, Griffin SJ, Walter FM.

Br J Cancer. 2015 Dec 22;113(12):1645-50. doi: 10.1038/bjc.2015.409. Epub 2015 Dec 3. Review.

43.

Caring for people living with, and beyond, cancer: an online survey of GPs in England.

Walter FM, Usher-Smith JA, Yadlapalli S, Watson E.

Br J Gen Pract. 2015 Nov;65(640):e761-8. doi: 10.3399/bjgp15X687409.

44.

Risk Prediction Models for Colorectal Cancer: A Systematic Review.

Usher-Smith JA, Walter FM, Emery JD, Win AK, Griffin SJ.

Cancer Prev Res (Phila). 2016 Jan;9(1):13-26. doi: 10.1158/1940-6207.CAPR-15-0274. Epub 2015 Oct 13. Review.

45.

Symptom appraisal and healthcare-seeking for symptoms suggestive of colorectal cancer: a qualitative study.

Hall N, Birt L, Banks J, Emery J, Mills K, Johnson M, Rubin GP, Hamilton W, Walter FM.

BMJ Open. 2015 Oct 9;5(10):e008448. doi: 10.1136/bmjopen-2015-008448.

46.

Total skin self-examination at home for people treated for cutaneous melanoma: development and pilot of a digital intervention.

Murchie P, Allan JL, Brant W, Dennis M, Hall S, Masthoff J, Walter FM, Johnston M.

BMJ Open. 2015 Aug 6;5(8):e007993. doi: 10.1136/bmjopen-2015-007993.

47.

Seasonal variation in diagnosis of invasive cutaneous melanoma in Eastern England and Scotland.

Walter FM, Abel GA, Lyratzopoulos G, Melia J, Greenberg D, Brewster DH, Butler H, Corrie PG, Campbell C.

Cancer Epidemiol. 2015 Aug;39(4):554-61. doi: 10.1016/j.canep.2015.06.006. Epub 2015 Jul 2.

48.

The role of emotions in time to presentation for symptoms suggestive of cancer: a systematic literature review of quantitative studies.

Balasooriya-Smeekens C, Walter FM, Scott S.

Psychooncology. 2015 Dec;24(12):1594-604. doi: 10.1002/pon.3833. Epub 2015 May 18. Review.

PMID:
25989295
49.

Protocol for the CHEST Australia Trial: a phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer.

Murray SR, Murchie P, Campbell N, Walter FM, Mazza D, Habgood E, Kutzer Y, Martin A, Goodall S, Barnes DJ, Emery JD.

BMJ Open. 2015 May 18;5(5):e008046. doi: 10.1136/bmjopen-2015-008046.

50.

Quantifying the risk of Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a case-control study using electronic records.

Shephard EA, Neal RD, Rose PW, Walter FM, Hamilton WT.

Br J Gen Pract. 2015 May;65(634):e289-94. doi: 10.3399/bjgp15X684805.

Supplemental Content

Loading ...
Support Center